157 related articles for article (PubMed ID: 36861082)
1. A case report of necrotizing enterocolitis in a moderately preterm neonate with LCHADD-A call to focus on the basics while utilizing advanced new therapies.
Metzler M; Burns W; Mitchell C; Napolitano S; Chaudhari BP
Front Pediatr; 2023; 11():1081802. PubMed ID: 36861082
[TBL] [Abstract][Full Text] [Related]
2. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
[TBL] [Abstract][Full Text] [Related]
3. Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study.
Vockley J; Longo N; Madden M; Dwyer L; Mu Y; Chen CY; Cataldo J
Clin Nutr ESPEN; 2021 Feb; 41():293-298. PubMed ID: 33487279
[TBL] [Abstract][Full Text] [Related]
4. Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program.
Vockley J; Enns GM; Ramirez AN; Bedrosian CL; Reineking B; Lu X; Ray K; Rahman S; Marsden D
Mol Genet Metab; 2022 Jun; 136(2):152-162. PubMed ID: 35459555
[TBL] [Abstract][Full Text] [Related]
5. Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
Norris MK; Scott AI; Sullivan S; Chang IJ; Lam C; Sun A; Hahn S; Thies JM; Gunnarson M; McKean KN; Merritt JL
JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):230-238. PubMed ID: 33085788
[TBL] [Abstract][Full Text] [Related]
6. Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders.
Zöggeler T; Stock K; Jörg-Streller M; Spenger J; Konstantopoulou V; Hufgard-Leitner M; Scholl-Bürgi S; Karall D
Orphanet J Rare Dis; 2021 Jan; 16(1):28. PubMed ID: 33446227
[TBL] [Abstract][Full Text] [Related]
7. Food protein-induced enterocolitis syndrome presenting after necrotizing enterocolitis in a preterm neonate: a case report.
Lu Y; Zhang ZQ
Transl Pediatr; 2021 May; 10(5):1393-1398. PubMed ID: 34189099
[TBL] [Abstract][Full Text] [Related]
8. Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.
Vockley J; Charrow J; Ganesh J; Eswara M; Diaz GA; McCracken E; Conway R; Enns GM; Starr J; Wang R; Abdenur JE; Sanchez-de-Toledo J; Marsden DL
Mol Genet Metab; 2016 Nov; 119(3):223-231. PubMed ID: 27590926
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.
Guffon N; Mochel F; Schiff M; De Lonlay P; Douillard C; Vianey-Saban C
Mol Genet Metab; 2021 Apr; 132(4):227-233. PubMed ID: 33610471
[TBL] [Abstract][Full Text] [Related]
10. Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program.
Yang E; Kruger E; Yin D; Mace K; Tierney M; Liao N; Cibelli E; Drozd D; Ross N; Deering KL; Herout P; Harshaw Q; Shillington A; Thomas N; Marsden D; Kritzer A; Vockley J
Mol Genet Metab; 2024 May; 142(1):108350. PubMed ID: 38458123
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
12. Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.
Vockley J; Burton B; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman K; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Cataldo J
J Inherit Metab Dis; 2021 Jan; 44(1):253-263. PubMed ID: 32885845
[TBL] [Abstract][Full Text] [Related]
13. Synbiotics for decreasing incidence of necrotizing enterocolitis among preterm neonates - a randomized controlled trial.
Nandhini LP; Biswal N; Adhisivam B; Mandal J; Bhat B V; Mathai B
J Matern Fetal Neonatal Med; 2016 Mar; 29(5):821-5. PubMed ID: 25754214
[TBL] [Abstract][Full Text] [Related]
14. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
Pammi M; Suresh G
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007137. PubMed ID: 28658720
[TBL] [Abstract][Full Text] [Related]
15. Use of skimmed breast milk for an infant with a long-chain fatty acid oxidation disorder: A novel therapeutic intervention.
Kritzer A; Tarrant S; Sussman-Karten K; Barbas K
JIMD Rep; 2020 Sep; 55(1):44-50. PubMed ID: 32905135
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
AlFaleh K; Anabrees J
Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin.
Lee SK; Gosselin NH; Jomphe C; McKeever K; Putnam W
Clin Pharmacol Drug Dev; 2022 Nov; 11(11):1264-1272. PubMed ID: 35908210
[TBL] [Abstract][Full Text] [Related]
18. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
[TBL] [Abstract][Full Text] [Related]
19. A novel
Dessein AF; Hebbar E; Vamecq J; Lebredonchel E; Devos A; Ghoumid J; Mention K; Dobbelaere D; Chevalier-Curt MJ; Fontaine M; Defoort S; Smirnov V; Douillard C; Dhaenens CM
Mol Genet Metab Rep; 2022 Jun; 31():100860. PubMed ID: 35782617
[TBL] [Abstract][Full Text] [Related]
20. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.
Gillingham M; Van Calcar S; Ney D; Wolff J; Harding C
J Inherit Metab Dis; 1999 Apr; 22(2):123-31. PubMed ID: 10234607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
